Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

HealthLynked (HLYK) Return on Sales (2016 - 2025)

HealthLynked (HLYK) has disclosed Return on Sales for 10 consecutive years, with 1.71% as the latest value for Q4 2025.

  • Quarterly Return on Sales fell 50.0% to 1.71% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 1.02% through Dec 2025, up 53.0% year-over-year, with the annual reading at 1.02% for FY2025, 53.0% up from the prior year.
  • Return on Sales for Q4 2025 was 1.71% at HealthLynked, down from 1.36% in the prior quarter.
  • The five-year high for Return on Sales was 1.5% in Q1 2023, with the low at 4.38% in Q1 2021.
  • Average Return on Sales over 5 years is 0.83%, with a median of 0.54% recorded in 2021.
  • The sharpest move saw Return on Sales crashed -395bps in 2021, then surged 427bps in 2022.
  • Over 5 years, Return on Sales stood at 1.45% in 2021, then soared by 90bps to 0.14% in 2022, then surged by 100bps to 0.0% in 2023, then plummeted by -4332888bps to 1.21% in 2024, then plummeted by -41bps to 1.71% in 2025.
  • According to Business Quant data, Return on Sales over the past three periods came in at 1.71%, 1.36%, and 0.74% for Q4 2025, Q3 2025, and Q2 2025 respectively.